Anti-B4GA1/ B4GAT1/ B3GN-T1 functional antibody

Anti-B4GA1/ B4GAT1/ B3GN-T1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to B4GAT1/B4GAT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1609-Ab-1/ GM-Tg-hg-SE1609-Ab-2Anti-Human B4GAT1 monoclonal antibodyHuman
GM-Tg-rg-SE1609-Ab-1/ GM-Tg-rg-SE1609-Ab-2Anti-Rat B4GAT1 monoclonal antibodyRat
GM-Tg-mg-SE1609-Ab-1/ GM-Tg-mg-SE1609-Ab-2Anti-Mouse B4GAT1 monoclonal antibodyMouse
GM-Tg-cynog-SE1609-Ab-1/ GM-Tg-cynog-SE1609-Ab-2Anti-Cynomolgus/ Rhesus macaque B4GAT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1609-Ab-1/ GM-Tg-felg-SE1609-Ab-2Anti-Feline B4GAT1 monoclonal antibodyFeline
GM-Tg-cang-SE1609-Ab-1/ GM-Tg-cang-SE1609-Ab-2Anti-Canine B4GAT1 monoclonal antibodyCanine
GM-Tg-bovg-SE1609-Ab-1/ GM-Tg-bovg-SE1609-Ab-2Anti-Bovine B4GAT1 monoclonal antibodyBovine
GM-Tg-equg-SE1609-Ab-1/ GM-Tg-equg-SE1609-Ab-2Anti-Equine B4GAT1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1609-Ab-1/ GM-Tg-hg-SE1609-Ab-2; GM-Tg-rg-SE1609-Ab-1/ GM-Tg-rg-SE1609-Ab-2;
GM-Tg-mg-SE1609-Ab-1/ GM-Tg-mg-SE1609-Ab-2; GM-Tg-cynog-SE1609-Ab-1/ GM-Tg-cynog-SE1609-Ab-2;
GM-Tg-felg-SE1609-Ab-1/ GM-Tg-felg-SE1609-Ab-2; GM-Tg-cang-SE1609-Ab-1/ GM-Tg-cang-SE1609-Ab-2;
GM-Tg-bovg-SE1609-Ab-1/ GM-Tg-bovg-SE1609-Ab-2; GM-Tg-equg-SE1609-Ab-1/ GM-Tg-equg-SE1609-Ab-2
Products NameAnti-B4GAT1 monoclonal antibody
Formatmab
Target NameB4GAT1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-B4GAT1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1609-Ag-1Recombinant multi-species B4GA1/ B4GAT1/ B3GN-T1 protein


    Target information

    Target IDGM-SE1609
    Target NameB4GAT1
    Gene ID11041,108902,293667,714270,476013,101084574,618055,100058396
    Gene Symbol and Synonyms1500032M01Rik,B3GN-T1,B3GNT1,B3GNT6,B4GAT1,BETA3GNT1,BETA3GNTI,iGAT,iGNT,MDDGA13
    Uniprot AccessionO43505,Q5EA01
    Uniprot Entry NameB4GA1_HUMAN,B4GA1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174684
    Target ClassificationN/A

    The target: B4GAT1, gene name: B4GAT1, also named as B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, MDDGA13, iGAT, iGNT. This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase family. This enzyme is a type II transmembrane protein. It is essential for the synthesis of poly-N-acetyllactosamine, a determinant for the blood group i antigen. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.